Why Idiopathic Pulmonary Fibrosis (IPF) is Often Misdiagnosed

“Professor Vincent Cottin, from National Reference Center for Rare Pulmonary Diseases, Université Claude Bernard Lyon 1, Lyon, discusses why idiopathic pulmonary fibrosis (IPF) is often misdiagnosed.” Read more about idiopathic pulmonary fibrosis: https://bit.ly/1QiRmr3…

Medical device company XENiOS recently announced that it has invested $2.6 million in XOR-Labs Toronto, a spin-off of Toronto General Hospital at University Health Network (UHN), a world-leading center for lung transplantation. The startup company’s organ repair technology has the potential to help thousands of patients suffering from respiratory diseases, including pulmonary…

Redwood City, California-based Third Rock Ventures, LLC, a healthcare venture firm, recently announced $45 million in Series A financing to launch the biotechnology start-up company Pliant Therapeutics, Inc., with a mandate to discover, develop, and commercialize breakthrough drug treatments for fibrotic diseases. Pliant’s product engine has the potential to address the needs…

“Professor Ulrich Costabel, from the Department of Pneymonology and Allergology, Ruhrlandklinik, Essen, discusses some questions and possible causes of idiopathic pulmonary fibrosis (IPF).” Read more about pulmonary fibrosis: https://bit.ly/1lfMsiZ…

https://www.youtube.com/watch?v=f_drG3aijSU “Kearni Warren sits down with Gerard Criner, M.D. to learn more about pulmonary fibrosis and some of the treatment options for patients.” Learn more about pulmonary fibrosis: https://bit.ly/1lfMsiZ…

Last week’s hot topic on pulmonary fibrosis was Traditional Chinese Medicine Eased Inflammation, Fibrosis in Animal PF Model written by Magdalena Kegel. This articles focus on a study from the University of Madras, India, which showed that celastrol — a component of an extract from the Thunder…